STRYKER CORP APIC, Share-based Payment Arrangement, Increase for Cost Recognition
STRYKER CORP (SYK) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $85.00 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-27.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2017-10-27
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2017-09-30 was $27.00M, a 22.73% increase year-over-year.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2017-06-30 was $26.00M, a 23.81% increase year-over-year.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2017-03-31 was $32.00M, a 14.29% increase year-over-year.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2016-12-31 was $26.00M, a 23.81% increase year-over-year.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2016 was $97.00M, a 12.79% increase from fiscal 2015.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2015 was $86.00M, a 11.69% increase from fiscal 2014.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2014 was $77.00M, a 1.32% increase from fiscal 2013.
- STRYKER CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2013 was $76.00M, a 1.33% increase from fiscal 2012.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2017-09-30 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $53.00M derived: sum of 2 quarters · filed 2017-10-27 | $85.00M 10-Q · filed 2017-10-27 | $111.00M derived: sum of 4 quarters · filed 2017-10-27 | |
| 2017-06-30 | $26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $58.00M 10-Q · filed 2017-07-28 | $84.00M derived: sum of 3 quarters · filed 2017-07-28 | $106.00M derived: sum of 4 quarters · filed 2017-07-28 | |
| 2017-03-31 | $32.00M 10-Q · filed 2017-04-27 | $58.00M derived: sum of 2 quarters · filed 2017-04-27 | $80.00M derived: sum of 3 quarters · filed 2017-04-27 | $101.00M derived: sum of 4 quarters · filed 2017-04-27 | |
| 2016-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $48.00M derived: sum of 2 quarters · filed 2017-02-09 | $69.00M derived: sum of 3 quarters · filed 2017-02-09 | $97.00M 10-K · filed 2017-02-09 | |
| 2016-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $43.00M derived: sum of 2 quarters · filed 2016-10-28 | $71.00M 10-Q · filed 2016-10-28 | $92.00M derived: sum of 4 quarters · filed 2017-02-09 | |
| 2016-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-22 | $49.00M 10-Q · filed 2016-07-22 | $70.00M derived: sum of 3 quarters · filed 2017-02-09 | $91.00M derived: sum of 4 quarters · filed 2017-02-09 | |
| 2016-03-31 | $28.00M 10-Q · filed 2016-04-22 | $49.00M derived: sum of 2 quarters · filed 2017-02-09 | $70.00M derived: sum of 3 quarters · filed 2017-02-09 | $91.00M derived: sum of 4 quarters · filed 2017-02-09 | |
| 2015-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $42.00M derived: sum of 2 quarters · filed 2017-02-09 | $63.00M derived: sum of 3 quarters · filed 2017-02-09 | $86.00M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23 | $42.00M derived: sum of 2 quarters · filed 2015-10-23 | $65.00M 10-Q · filed 2015-10-23 | $84.00M derived: sum of 4 quarters · filed 2017-02-09 | |
| 2015-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $44.00M 10-Q · filed 2015-07-29 | $63.00M derived: sum of 3 quarters · filed 2017-02-09 | $80.00M derived: sum of 4 quarters · filed 2017-02-09 | |
| 2015-03-31 | $23.00M 10-Q · filed 2015-04-30 | $42.00M derived: sum of 2 quarters · filed 2017-02-09 | $59.00M derived: sum of 3 quarters · filed 2017-02-09 | $79.00M derived: sum of 4 quarters · filed 2017-02-09 | |
| 2014-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $36.00M derived: sum of 2 quarters · filed 2017-02-09 | $56.00M derived: sum of 3 quarters · filed 2017-02-09 | $77.00M 10-K · filed 2017-02-09 | |
| 2014-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23 | $37.00M derived: sum of 2 quarters · filed 2014-10-23 | $58.00M 10-Q · filed 2014-10-23 | $77.00M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2014-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $41.00M 10-Q · filed 2014-07-24 | $60.00M derived: sum of 3 quarters · filed 2016-02-11 | $79.00M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2014-03-31 | $21.00M 10-Q · filed 2014-04-24 | $40.00M derived: sum of 2 quarters · filed 2016-02-11 | $59.00M derived: sum of 3 quarters · filed 2016-02-11 | $77.00M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2013-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $38.00M derived: sum of 2 quarters · filed 2016-02-11 | $56.00M derived: sum of 3 quarters · filed 2016-02-11 | $76.00M 10-K · filed 2016-02-11 | |
| 2013-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $37.00M derived: sum of 2 quarters · filed 2013-10-23 | $57.00M 10-Q · filed 2013-10-23 | $75.00M derived: sum of 4 quarters · filed 2015-02-12 | |
| 2013-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $38.00M 10-Q · filed 2013-07-23 | $56.00M derived: sum of 3 quarters · filed 2015-02-12 | $74.00M derived: sum of 4 quarters · filed 2015-02-12 | |
| 2013-03-31 | $20.00M 10-Q · filed 2013-04-30 | $38.00M derived: sum of 2 quarters · filed 2015-02-12 | $56.00M derived: sum of 3 quarters · filed 2015-02-12 | $74.00M derived: sum of 4 quarters · filed 2015-02-12 | |
| 2012-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $36.00M derived: sum of 2 quarters · filed 2015-02-12 | $54.00M derived: sum of 3 quarters · filed 2015-02-12 | $75.00M 10-K · filed 2015-02-12 | |
| 2012-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-22 | $36.00M derived: sum of 2 quarters · filed 2012-10-22 | $57.00M 10-Q · filed 2012-10-22 | $74.00M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $39.00M 10-Q · filed 2012-07-24 | $56.00M derived: sum of 3 quarters · filed 2014-02-13 | $75.30M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-03-31 | $21.00M 10-Q · filed 2012-04-24 | $38.00M derived: sum of 2 quarters · filed 2014-02-13 | $57.30M derived: sum of 3 quarters · filed 2014-02-13 | $76.40M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2011-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $36.30M derived: sum of 2 quarters · filed 2014-02-13 | $55.40M derived: sum of 3 quarters · filed 2014-02-13 | $75.00M 10-K · filed 2014-02-13 | |
| 2011-09-30 | $19.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $38.40M derived: sum of 2 quarters · filed 2011-10-28 | $58.00M 10-Q · filed 2011-10-28 | $73.40M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-06-30 | $19.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $38.70M 10-Q · filed 2011-07-28 | $54.10M derived: sum of 3 quarters · filed 2013-02-27 | $71.60M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-03-31 | $19.60M 10-Q · filed 2011-05-04 | $35.00M derived: sum of 2 quarters · filed 2013-02-27 | $52.50M derived: sum of 3 quarters · filed 2013-02-27 | $69.80M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2010-12-31 | $15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $32.90M derived: sum of 2 quarters · filed 2013-02-27 | $50.20M derived: sum of 3 quarters · filed 2013-02-27 | $69.00M 10-K · filed 2013-02-27 | $68.80M 10-K · filed 2011-02-18 |
| 2010-09-30 | $17.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $34.80M derived: sum of 2 quarters · filed 2010-11-04 | $53.60M 10-Q · filed 2010-11-04 | $68.60M derived: sum of 4 quarters · filed 2012-02-13 | |
| 2010-06-30 | $17.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $36.10M 10-Q · filed 2010-08-09 | $51.10M derived: sum of 3 quarters · filed 2012-02-13 | $66.40M derived: sum of 4 quarters · filed 2012-02-13 | |
| 2010-03-31 | $18.80M 10-Q · filed 2010-04-29 | $33.80M derived: sum of 2 quarters · filed 2012-02-13 | $49.10M derived: sum of 3 quarters · filed 2012-02-13 | ||
| 2009-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $30.30M derived: sum of 2 quarters · filed 2012-02-13 | $62.00M 10-K · filed 2012-02-13 | $62.30M 10-K · filed 2010-02-26 | |
| 2009-09-30 | $15.30M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-09 | $47.00M 10-Q · filed 2009-11-09 | |||
| 2009-06-30 | $31.70M 10-Q/A · filed 2009-09-03 | ||||
| 2008-12-31 | $65.50M 10-K · filed 2011-02-18 | ||||
| 2007-12-31 | $62.40M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |